Filing Details
- Accession Number:
- 0001628280-25-001732
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-16 16:37:31
- Reporting Period:
- 2025-01-15
- Accepted Time:
- 2025-01-16 16:37:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402051 | William Lewis | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chair And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-01-15 | 18,750 | $22.76 | 411,339 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-01-15 | 6,636 | $69.39 | 404,703 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-01-15 | 22,696 | $70.32 | 382,007 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-01-15 | 2,473 | $71.05 | 379,534 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2025-01-15 | 6,830 | $10.85 | 240,754 | No | 4 | M | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-01-15 | 1,499 | $69.40 | 239,255 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-01-15 | 4,700 | $70.31 | 234,555 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-01-15 | 631 | $71.01 | 233,924 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2025-01-15 | 18,750 | $0.00 | 18,750 | $22.76 |
Common Stock | Stock Option (right to buy) | Disposition | 2025-01-15 | 6,830 | $0.00 | 6,830 | $10.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,000 | 2025-05-21 | No | 4 | M | Direct | |
218,630 | 2026-05-19 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 50,500 | Indirect | By the William Lewis Family Legacy Trust |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 6,636 shares sold at prices ranging from $68.87 to $69.86 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 22,696 shares sold at prices ranging from $69.89 to $70.89 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 2,473 shares sold at prices ranging from $70.89 to $71.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 1,499 shares sold at prices ranging from $68.87 to $69.87 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 4,700 shares sold at prices ranging from $69.91 to $70.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 631 shares sold at prices ranging from $70.92 to $71.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.